⌘K

Evgen Pharma plc RNS

Evgen Pharma plc (EVG) RNS Announcements | Ticker | Ticker

Date	Time	Date	TitleTitle (filtered)
10/10/22	11:00:36	10 Oct 2022	Price Monitoring Extension	Price Monitoring Extension
10/10/22	07:00:07	10 Oct 2022	SFX-01 licensing deal for up to $160.5m	SFX-01 licensing deal for up to $160.5m
29/09/22	07:00:07	29 Sept 2022	Regulatory approval for healthy volunteer study	Regulatory approval for healthy volunteer study
22/07/22	07:00:02	22 Jul 2022	Result of AGM	Result of AGM
14/07/22	12:43:38	14 Jul 2022	Investor Presentation	Investor Presentation
06/07/22	12:25:32	6 Jul 2022	Notice of AGM	Notice of AGM
13/06/22	07:00:07	13 Jun 2022	Collaboration with University of Michigan	Collaboration with University of Michigan
08/06/22	07:00:10	8 Jun 2022	Full Year Results	Full Year Results
07/06/22	07:00:08	7 Jun 2022	Notice of Results	Notice of Results
25/05/22	07:00:10	25 May 2022	Collaboration with Università Sapienza di Roma	Collaboration with Università Sapienza di Roma
29/04/22	14:39:40	29 Apr 2022	Holding(s) in Company	Holding(s) in Company
15/03/22	14:05:48	15 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn
15/03/22	14:00:43	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension
07/03/22	07:00:11	7 Mar 2022	Manchester Breast Centre collaboration expanded	Manchester Breast Centre collaboration expanded
18/01/22	07:00:04	18 Jan 2022	Option over new sulforaphane analogues	Option over new sulforaphane analogues
11/01/22	07:00:06	11 Jan 2022	Progress with UK and US regulators for 2022 trials	Progress with UK and US regulators for 2022 trials
30/12/21	11:35:19	30 Dec 2021	Holding(s) in Company	Holding(s) in Company
08/12/21	14:08:33	8 Dec 2021	Grant of Options	Grant of Options
07/12/21	07:00:02	7 Dec 2021	Half-year Report	Half-year Report
23/11/21	07:00:11	23 Nov 2021	Notice of Results	Notice of Results
10/11/21	07:00:06	10 Nov 2021	Publication of data on SFX-01 in glioblastoma	Publication of data on SFX-01 in glioblastoma
19/10/21	14:39:16	19 Oct 2021	Holding(s) in Company	Holding(s) in Company
20/09/21	07:00:09	20 Sept 2021	Publication of data in glioblastoma cells	Publication of data in glioblastoma cells
02/09/21	14:32:34	2 Sept 2021	Holding(s) in Company	Holding(s) in Company
02/09/21	14:06:09	2 Sept 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
02/09/21	14:00:47	2 Sept 2021	Price Monitoring Extension	Price Monitoring Extension
02/09/21	11:05:40	2 Sept 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
02/09/21	11:01:52	2 Sept 2021	Glioma Orphan Drug designation granted by FDA	Glioma Orphan Drug designation granted by FDA
02/09/21	11:00:34	2 Sept 2021	Price Monitoring Extension	Price Monitoring Extension
25/08/21	16:42:34	25 Aug 2021	Holding(s) in Company	Holding(s) in Company
24/08/21	16:41:10	24 Aug 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
24/08/21	16:36:08	24 Aug 2021	Price Monitoring Extension	Price Monitoring Extension

Showing 51–82 of 82 announcements

Date	Time	Date	TitleTitle (filtered)
10/10/22	11:00:36	10 Oct 2022	Price Monitoring Extension	Price Monitoring Extension
10/10/22	07:00:07	10 Oct 2022	SFX-01 licensing deal for up to $160.5m	SFX-01 licensing deal for up to $160.5m
29/09/22	07:00:07	29 Sept 2022	Regulatory approval for healthy volunteer study	Regulatory approval for healthy volunteer study
22/07/22	07:00:02	22 Jul 2022	Result of AGM	Result of AGM
14/07/22	12:43:38	14 Jul 2022	Investor Presentation	Investor Presentation
06/07/22	12:25:32	6 Jul 2022	Notice of AGM	Notice of AGM
13/06/22	07:00:07	13 Jun 2022	Collaboration with University of Michigan	Collaboration with University of Michigan
08/06/22	07:00:10	8 Jun 2022	Full Year Results	Full Year Results
07/06/22	07:00:08	7 Jun 2022	Notice of Results	Notice of Results
25/05/22	07:00:10	25 May 2022	Collaboration with Università Sapienza di Roma	Collaboration with Università Sapienza di Roma
29/04/22	14:39:40	29 Apr 2022	Holding(s) in Company	Holding(s) in Company
15/03/22	14:05:48	15 Mar 2022	Second Price Monitoring Extn	Second Price Monitoring Extn
15/03/22	14:00:43	15 Mar 2022	Price Monitoring Extension	Price Monitoring Extension
07/03/22	07:00:11	7 Mar 2022	Manchester Breast Centre collaboration expanded	Manchester Breast Centre collaboration expanded
18/01/22	07:00:04	18 Jan 2022	Option over new sulforaphane analogues	Option over new sulforaphane analogues
11/01/22	07:00:06	11 Jan 2022	Progress with UK and US regulators for 2022 trials	Progress with UK and US regulators for 2022 trials
30/12/21	11:35:19	30 Dec 2021	Holding(s) in Company	Holding(s) in Company
08/12/21	14:08:33	8 Dec 2021	Grant of Options	Grant of Options
07/12/21	07:00:02	7 Dec 2021	Half-year Report	Half-year Report
23/11/21	07:00:11	23 Nov 2021	Notice of Results	Notice of Results
10/11/21	07:00:06	10 Nov 2021	Publication of data on SFX-01 in glioblastoma	Publication of data on SFX-01 in glioblastoma
19/10/21	14:39:16	19 Oct 2021	Holding(s) in Company	Holding(s) in Company
20/09/21	07:00:09	20 Sept 2021	Publication of data in glioblastoma cells	Publication of data in glioblastoma cells
02/09/21	14:32:34	2 Sept 2021	Holding(s) in Company	Holding(s) in Company
02/09/21	14:06:09	2 Sept 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
02/09/21	14:00:47	2 Sept 2021	Price Monitoring Extension	Price Monitoring Extension
02/09/21	11:05:40	2 Sept 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
02/09/21	11:01:52	2 Sept 2021	Glioma Orphan Drug designation granted by FDA	Glioma Orphan Drug designation granted by FDA
02/09/21	11:00:34	2 Sept 2021	Price Monitoring Extension	Price Monitoring Extension
25/08/21	16:42:34	25 Aug 2021	Holding(s) in Company	Holding(s) in Company
24/08/21	16:41:10	24 Aug 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
24/08/21	16:36:08	24 Aug 2021	Price Monitoring Extension	Price Monitoring Extension

Showing 51–82 of 82 announcements